NCT01226966View on ClinicalTrials.gov

Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

3,152

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

liraglutide

Prescription is done at the discretion of the prescribing physician as part of normal clinical routine.

Trial Locations (1)

92932

Novo Nordisk Investigational Site, Paris La Défense Cedex

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY